Fish Oil Reached the Brain—So Why Didn’t It Improve Memory?
Key Takeaways
-
In a two-year randomized, double-blind trial, 365 adults ages 55 to 80 received either 2,000 mg of DHA daily or a placebo.
-
DHA levels in cerebrospinal fluid rose by an average of 17% after six months, showing that the supplement reached the central nervous system.
-
Despite that increase, the DHA group did not outperform placebo on memory or broader cognitive testing, and imaging did not show less hippocampal shrinkage.
-
The findings apply to this high-dose DHA intervention in this specific higher-risk group—not to every fish-oil product, every outcome, or dietary omega-3 intake more broadly.
Reaching the Brain Isn’t the Same as Changing It
The study answered an important first question: DHA from the supplement did enter the fluid surrounding the brain and spinal cord. But biology has a second, harder step—whether the brain can absorb, process, and use that added DHA in a way that changes cognitive outcomes.
In this trial, higher DHA availability did not translate into measurable improvements in memory, thinking, or hippocampal volume over two years. That does not mean DHA is unimportant; it means more DHA alone was not sufficient to shift these outcomes in the population studied.
Food Comes With Context
Omega-3-rich foods are consumed within a broader dietary pattern that includes protein, vitamins, minerals, fiber, and other fats. The researchers suggest that this nutritional context—along with age, genetic background, diet, and overall health—may influence how effectively the brain uses omega-3s.
This is a hypothesis, not a direct test of food versus supplements. The trial did not compare fish oil with eating fish or with a Mediterranean-style dietary intervention.
What the Study Does—and Doesn’t—Say
The result is not a verdict against supplements. Supplements can be useful for specific nutritional needs and clinically supported indications, but they should not be assumed to reproduce every potential effect of a nutrient-rich diet.
For cognitive protection specifically, this trial found no evidence that high-dose DHA supplementation alone prevented decline or structural brain changes in these participants. The next question is not simply whether omega-3s reach the brain, but which people, forms, and biological conditions might allow those nutrients to be used more effectively.
References:
- Hussein N. Yassine, Sara Ghasem Pour, Marlene Juarez, Isabella C. Arrelanas, Nada Ali, Dante Dikeman, Ashley Sanchez, Jackson Park, Bilal Kerman, Marlon V. Duro, Isaac Asante, Stan Louie, Naoko Kono, Lina M. D\'Orazio, Helena Chui, Wendy J. Mack, Michael G. Harrington, Meredith N. Braskie, Lon S. Schneider. CNS target engagement of high-dose DHA supplementation in older adults at risk: a randomised, double-blind, placebo-controlled trial. eBioMedicine, 2026; 129: 106316 DOI: 10.1016/j.ebiom.2026.106316